CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 116 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $238,227 | -30.1% | 5,345 | -56.0% | 0.16% | -30.6% |
| Q3 2022 | $341,000 | +65.5% | 12,135 | +59.1% | 0.24% | +59.9% |
| Q2 2022 | $206,000 | -21.1% | 7,625 | -0.7% | 0.15% | -11.4% |
| Q1 2022 | $261,000 | -17.4% | 7,675 | -6.2% | 0.17% | -14.4% |
| Q4 2021 | $316,000 | +6.8% | 8,183 | +49.1% | 0.19% | 0.0% |
| Q3 2021 | $296,000 | +37.7% | 5,489 | -14.4% | 0.19% | +47.0% |
| Q2 2021 | $215,000 | -17.0% | 6,416 | -56.6% | 0.13% | -25.4% |
| Q4 2020 | $259,000 | +38.5% | 14,791 | +17.6% | 0.18% | +17.2% |
| Q3 2020 | $187,000 | – | 12,581 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|